Search

everythinglearnresearchcommunity

for

Search:↓

Neural progenitor cell-derived nanovesicles help hair growth by activating a key signaling pathway.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

Super-enhancers controlled by pioneer factors like SOX9 are crucial for stem cell adaptability and identity.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

Androgens may cause hair loss by increasing TGF-beta1 from scalp cells, which inhibits hair cell growth.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Minoxidil boosts hair growth by increasing cell production and survival.

Oxidative stress contributes to hair graying and loss as we age.

Asia has made significant progress in tissue engineering and regenerative medicine, but wider clinical use requires more development.

Minoxidil and finasteride effectively treat hair loss.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Fat tissue stem cells may help increase hair growth.

Melatonin helps hair growth in women with hair loss.

The representation of skin conditions in medical reviews partly matches their real-world impact.

PRP and HF-MSCs treatment improves hair growth, thickness, and density in androgenetic alopecia.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Notch-related genes play a key role in the development and cycling of hair follicles.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

Certain signals and genes play a key role in hair growth and regeneration, and understanding these could lead to new treatments for skin regeneration.

Oxidative stress damages hair and contributes to aging, and managing it can help maintain hair health.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.